 - Male or female, aged 18 to 30 years, inclusive, with a diagnosis of T1DM with an interval of 28-56 days between the initial diagnosis and the first dose of study drug. Documentation of the diagnosis of T1DM and not just insulin deficiency, including the date of diagnosis, must be obtained from the diagnosing physician. 